Possible involvement of DEC1 on the adverse effects of quinolone antibiotics

Toxicology

Volumn 271, Issue 1-2, 2010, Pages 1-4

  Shi, Xiaohong ^a,b   Zheng, Yan ^b,c   Ma, Wanshan ^a   Wang, Yunshan ^b  

^a SHANDONG UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c Shandong Province Key Laboratory for Tumor Target Molecule   (China)

Author keywords

Adverse effects; Antibiotics; DEC1; Quinolones

Indexed keywords

DIFFERENTIATED EMBRYO CHONDROCYTE EXPRESSED GENE 1 PROTEIN; GATIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADIPOGENESIS; AGITATION; ANXIETY; ARTHRALGIA; ARTHRITIS; ARTHROPATHY; ARTICULAR CARTILAGE; CENTRAL NERVOUS SYSTEM DISEASE; CHONDROGENESIS; CIRCADIAN RHYTHM; CONFUSION; DRUG INDUCED DISEASE; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSOMNIA; JOINT SWELLING; NERVE CELL DIFFERENTIATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PHOTOTOXICITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PSYCHOSIS; REVIEW; SIDE EFFECT; TENDON DISEASE; TREMOR; ULTRAVIOLET RADIATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOOD GLUCOSE; CHONDROCYTES; HOMEODOMAIN PROTEINS; HUMANS; NEURONS; QUINOLONES;

EID: 77951298809     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.03.001     Document Type: Review

References (36)

1. Baranowski M. Biological role of liver X receptors. J. Physiol. Pharmacol. 2008, 7:31-55.
2. Bek M.J., Wahle S., Müller B., Benzing T., Huber T.B., Kretzler M., Cohen C., Busse-Grawitz A., Pavenstädt H. Stra13, a prostaglandin E2-induced gene, regulates the cellular redox state of podocytes. FASEB J. 2003, 17:682-684.
3. Boudjelal M., Taneja R., Matsubara S., Bouillet P., Dolle P., Chambon P. Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells. J. Genes Dev. 1997, 11:2052-2065.
4. Burkhardt J.E., Hill M.A., Carlton W.W. Morphologic and biochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin. J. Toxicol. Pathol. 1992, 20:246-252.
5. Chen Q., Johnson D.M., Haudenschild D.R., Goetinck P.F. Progression and recapitulation of the chondrocyte differentiation program: cartilage matrix protein is a marker for cartilage maturation. J. Dev. Biol. 1995, 172:293-306.
6. Fish D.N. Fluoroquinolone adverse effects and drug interactions. Pharmacotherapy 2001, 21:253-272.
7. Goto K., Yabe K., Suzuki T., Takasuna K., Jindo T., Manabe S. Gene expression profiles in the articular cartilage of juvenile rats receiving the quinolone antibacterial agent ofloxacin. J. Toxicol. 2008, 249:204-213.
8. Honma S., Kawamoto T., Takagi Y., Fujimoto K., Sato F., Noshiro M., Kato Y., Honma K. Dec1 and Dec2 are regulators of the mammalian molecular clock. J. Nat. 2002, 419:841-844.
9. Iannini P.B. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations. J. Curr. Med. Res. Opin. 2007, 23:1403-1413.
10. Ivanova A., Liao S.Y., Lerman M.I., Ivanov S., Stanbridge E.J. STRA13 expression and subcellular localization in normal and tumour tissues: implications for use as a diagnostic and differentiation marker. J. Med. Genet. 2005, 42:565-576.
11. Iizuka K., Horikawa Y. Regulation of lipogenesis via BHLHB2/DEC1 and ChREBP feedback looping. J. Biochem. Biophys. Res. Commun. 2008, 374:95-100.
12. Jiang X., Tian F., Du Y., Copeland N.G., Jenkins N.A., Tessarollo L., Wu X., Pan H., Hu X.Z., Xu K., Kenney H., Egan S.E., Turley H., Harris A.L., Marini A.M., Lipsky R.H. BHLHB2 controls Bdnf promoter 4 activity and neuronal excitability. J. Neurosci. 2008, 28:1118-1130.
13. Kawamoto T., Noshiro M., Furukawa M., Honda K.K., Nakashima A., Ueshima T., Usui E., Katsura Y., Fujimoto K., Honma S., Honma K., Hamada T., Kato Y. Effects of fasting and re-feeding on the expression of Dec1, Per1, and other clock-related genes. J. Biochem. 2006, 140:401-408.
14. Kergosien N., Sautier J., Forest N. Gene and protein expression during differentiation and matrix mineralization in a chondrocyte cell culture system. J. Calcif. Tissue Int. 1998, 62:114-121.
15. Li Y., Bi Z., Yan B., Wan Y. UVB radiation induces expression of HIF-1alpha and VEGF through the EGFR/PI3K/DEC1 pathway. Int. J. Mol. Med. 2006, 18:713-719.
16. Nakashima A., Kawamoto T., Honda K.K., Ueshima T., Noshiro M., Iwata T., Fujimoto K., Kubo H., Honma S., Yorioka N., Kohno N., Kato Y. DEC1 modulates the circadian phase of clock gene expression. J. Mol. Cell. Biol. 2008, 28:4080-4092.
17. Neu H.C. Quinolone antimicrobial agents. J. Annu. Rev. Med. 1992, 43:465-486.
18. Noshiro M., Usui E., Kawamoto T., Sato F., Nakashima A., Ueshima T., Honda K., Fujimoto K., Honma S., Honma K., Makishima M., Kato Y. Liver X receptors (LXRalpha and LXRbeta) are potent regulators for hepatic Dec1 expression. J. Genes Cells 2009, 14:29-40.
19. Rome S., Meugnier E., Lecomte V., Berbe V., Besson J., Cerutti C., Pesenti S., Granjon A., Disse E., Clement K., Lefai E., Laville M., Vidal H. Microarray analysis of genes with impaired insulin regulation in the skeletal muscle of type 2 diabetic patients indicates the involvement of basic helix-loop-helix domain-containing, class B, 2 protein (BHLHB2). J. Diabetologia 2009, 52:1899-1912.
20. Rossner M.J., Dörr J., Gass P., Schwab M.H., Nave K.A. SHARPs: mammalian enhancer-of-split- and hairy-related proteins coupled to neuronal stimulation. J. Mol. Cell. Neurosci. 1997, 10:460-475.
21. Schmid T.M., Bonen D.K., Luchene L., Linsenmayer T.F. Late events in chondrocyte differentiation: hypertrophy, type X collagen synthesis and matrix calcification. J. In Vivo 1991, 5:533-540.
22. Shen M., Kawamoto T., Yan W., Nakamasu K., Tamagami M., Koyano Y., Noshiro M., Kato Y. Molecular characterization of the novel basic helix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes. J. Biochem. Biophys. Res. Commun. 1997, 236:294-298.
23. Shen M., Kawamoto T., Teramoto M., Makihira S., Fujimoto K., Yan W., Noshiro M., Kato Y. Induction of basic helix-loop-helix protein DEC1 (BHLHB2)/Stra13/Sharp2 in response to the cyclic adenosine monophosphate pathway. Eur. J. Cell Biol. 2001, 80:329-334.
24. Shen M., Yoshida E., Yan W., Kawamoto T., Suardita K., Koyano Y., Fujimoto K., Noshiro M., Kato Y. Basic helix-loop-helix protein DEC1 promotes chondrocyte differentiation at the early and terminal stages. J. Biol. Chem. 2002, 277:50112-50120.
25. Sheng Z.G., Peng S., Wang C.Y., Li H.B., Hajela R.K., Wang Y.E., Li Q.Q., Liu M.F., Dong Y.S., Han G. Apoptosis in microencapsulated juvenile rabbit chondrocytes induced by ofloxacin: role played by beta (1)-integrin receptor. J. Pharmacol. Exp. Ther. 2007, 322:155-165.
26. Shi J., Wittke-Thompson J.K., Badner J.A., Hattori E., Potash J.B., Willour V.L., McMahon F.J., Gershon E.S., Liu C. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am. J. Med. Genet. 2008, 147B:1047-1055.
27. Turley H., Wykoff C.C., Troup S., Watson P.H., Gatter K.C., Harris A.L. The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in human tissues and tumours. J. Pathol. 2004, 203:808-813.
28. Umezawa N., Arakane K., Ryu A., Mashiko S., Hirobe M., Nagano T. Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents. J. Arch. Biochem. Biophys. 1997, 342:275-278.
29. Vercherat C., Chung T.K., Yalcin S., Gulbagci N., Gopinadhan S., Ghaffari S., Taneja R. Stra13 regulates oxidative stress mediated skeletal muscle degeneration. J. Hum. Mol. Genet. 2009, 18:4304-4316.
30. Yamada K., Kawata H., Shou Z., Mizutani T., Noguchi T., Miyamoto K. Insulin induces the expression of the SHARP-2/Stra13/DEC1 gene via a phosphoinositide 3-kinase pathway. J. Biol. Chem. 2003, 278:30719-30724.
31. Yamada K., Miyamoto K. Basic helix-loop-helix transcription factors, BHLHB2 and BHLHB3; their gene expressions are regulated by multiple extracellular stimuli. J. Front. Biosci. 2005, 10:3151-3171.
32. Yamada K., Ogata-Kawata H., Matsuura K., Miyamoto K. SHARP-2/Stra13/DEC1 as a potential repressor of phosphoenolpyruvate carboxykinase gene expression. J. FEBS Lett. 2005, 579:1509-1514.
33. Yip C., Lee A.J. Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature. J. Clin. Ther. 2006, 28:1857-1866.
34. Yun Z., Maecker H.L., Johnson R.S., Giaccia A.J. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. J. Dev. Cell 2002, 2:331-341.
35. Zvonar R. Gatifloxacin-induced dysglycemia. Am. J. Health Syst. Pharm. 2006, 63:2087-2092.
36. Zvonic S., Ptitsyn A.A., Conrad S.A., Scott L.K., Floyd Z.E., Kilroy G., Wu X., Goh B.C., Mynatt R.L., Gimble J.M. Characterization of peripheral circadian clocks in adipose tissues. J. Diabetes 2006, 55:962-970.